The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer
- 1 April 2002
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 112 (5) , 380-385
- https://doi.org/10.1016/s0002-9343(01)01130-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Candida glabrata Fungemia Clinical Features of 139 PatientsMedicine, 1999
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY ProgramJournal of Clinical Microbiology, 1998
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- The Epidemiology of Hematogenous Candidiasis Caused by Different Candida SpeciesClinical Infectious Diseases, 1997
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceThe American Journal of Medicine, 1996
- Importance of Candida Species Other than C. albicans as Pathogens in Oncology PatientsClinical Infectious Diseases, 1995
- Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patientsAntimicrobial Agents and Chemotherapy, 1993
- Candidemia in Immunocompromised PatientsClinical Infectious Diseases, 1992
- Fungemia due to Torulopsis glabrata in the compromised hostCancer, 1976
- Torulopsis glabrata infections in patients with cancerThe American Journal of Medicine, 1976